ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Julia O'Sullivan und 17 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Laval University Cancer Research Center, 9 McMahon, Québec City, QCG1R 3S3, Canada. Hauptthemen laut MEDLINE: Poly Adenosine Diphosphate Ribose, Poly ADP Ribosylation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Canadian Institutes of Health Research, NCI.
Abstract (Originalsprache)
Zinc finger (ZNF) motifs are some of the most frequently occurring domains in the human genome. It was only recently that ZNF proteins emerged as key regulators of genome integrity in mammalian cells. In this study, we report a new role for the Krüppel-type ZNF-containing protein ZNF432 as a novel poly(ADP-ribose) (PAR) reader that regulates the DNA damage response. We show that ZNF432 is recruited to DNA lesions via DNA- and PAR-dependent mechanisms. Remarkably, ZNF432 stimulates PARP-1 activity in vitro and in cellulo. Knockdown of ZNF432 inhibits phospho-DNA-PKcs and increases RAD51 foci formation following irradiation. Moreover, purified ZNF432 preferentially binds single-stranded DNA and impairs EXO1-mediated DNA resection. Consequently, the loss of ZNF432 in a cellular system leads to resistance to PARP inhibitors while its overexpression results in sensitivity. Taken together, our results support the emerging concept that ZNF-containing proteins can modulate PARylation, which can be embodied by the pivotal role of ZNF432 to finely balance the outcome of PARPi response by regulating homologous recombination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Laval University Cancer Research Center, 9 McMahon, Québec City, QCG1R 3S3, Canada.
- CHU de Québec Research Center, CHUL Pavilion, Oncology Division, Laval University Cancer Research Center, 2705 Boulevard Laurier, Québec City, QCG1V 4G2, Canada.
- Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada.
- Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, Québec J1E 4K8, Canada.
ORCID-Profile: Larissa Milano, Scott H Kaufmann, Michael J Hendzel, Jean-Yves Masson
Förderung
- NCI NIH HHS
- Canadian Institutes of Health Research
- NCI
- Cancer Research Society
- Canada Research Chair in Genome Cell Biology and Dynamics
Zitieren
APA
O'Sullivan, J., Kothari, C., Caron, M. C., Gagné, J. P., Jin, Z., Nonfoux, L., Beneyton, A., Coulombe, Y., Thomas, M., Atalay, N., Meng, X. W., Milano, L., Jean, D., Boisvert, F. M., Kaufmann, S. H., Hendzel, M. J., Masson, J. Y., & Poirier, G. G. (2023). ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad791
Vancouver
O'Sullivan J, Kothari C, Caron MC, Gagné JP, Jin Z, Nonfoux L, et al. ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad791
BibTeX
@article{OSullivan2023,
author = {O'Sullivan, Julia and Kothari, Charu and Caron, Marie-Christine and Gagné, Jean-Philippe and Jin, Zhigang and Nonfoux, Louis and Beneyton, Adèle and Coulombe, Yan and Thomas, Mélissa and Atalay, Nurgul and Meng, X Wei and Milano, Larissa and Jean, Dominique and Boisvert, François-Michel and Kaufmann, Scott H and Hendzel, Michael J and Masson, Jean-Yves and Poirier, Guy G},
title = {ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad791}
}
EUVIMED